- Published at
- by seekingalpha.com
neutral
neutral
DiaSorin S.p.A. 2024 Q3 - Results - Earnings Call Presentation (OTCMKTS:DSRLF)
The following slide deck was published by DiaSorin S.p.A.
News for DiaSorin S.p.A. (DSRLF)
- Published at
- by globenewswire.com
mixedmixedThyroid Function Testing Market to hit USD 6.6 billion by 2032, says Global Market Insights Inc.
Thyroid function testing industry is projected to witness a CAGR of 6.1% during the period 2024-2032. This growth can be attributed to advancements in...- Published at
- by globenewswire.com
neutralneutralInfectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology
Infectious Disease Diagnostics Market size was valued at USD 22.94 billion in 2023 to USD 43.09 billion by 2031...- Published at
- by globenewswire.com
mixedmixedImmunoassay Market to Surpass Market Valuation of USD 54.27 Billion by 2031 | SkyQuest Technology
The immunoassay market is set for robust growth, projected to expand from USD 35.12 billion in 2023 to USD 54.27 billion by 2031, at a CAGR of 5.59%. Key...- Published at
- by globenewswire.com
mixedmixedInfluenza Diagnostics Market is Poised to Register CAGR of 3.5% by 2031 | SkyQuest Technology
Influenza Diagnostics Market will reach a value of USD 1.46 Billion by 2031, with a CAGR of 3.5% during the forecast period (2024-2031)....- Published at
- by globenewswire.com
mixedmixedNanomedicine Market to Hit USD 634.2 Billion by 2032; Improvements in Drug Delivery and Therapeutics Witness Rising Momentum
With rising chronic disease rates and increasing collaboration between pharmaceutical companies and academia, the nanomedicine market is poised for...- Published at
- by globenewswire.com
mixedmixedImmunoassay Market to Reach $61.6 Billion, Globally, by 2033 at 5.8% CAGR: Allied Market Research
Rising incidence of chronic diseases, growing adoption of point-of-care testing and increase in geriatric population are the major factors which drive the...- Published at
- by globenewswire.com
positivepositiveHepatitis E Diagnostic Tests Market to Surge USD 78.62 Million by 2032, Driven by 4.6% CAGR | Polaris Market Research
The market is growing due to surging cases of Hepatitis E, especially in advancing regions where sanitation is deficient and pollution is common....- Published at
- by seekingalpha.com
mixedmixedDiaSorin S.p.A. (DSRLF) Q2 2024 Earnings Call Transcript
DiaSorin S.p.A. (OTCPK:DSRLF) Q2 2024 Earnings Conference Call July 29, 2024 11:00 AM ETCompany ParticipantsCarlo Rosa - Chief Executive OfficerPiergiorgio...- Published at
- by seekingalpha.com
neutralneutralDiaSorin S.p.A. 2024 Q2 - Results - Earnings Call Presentation (OTCMKTS:DSRLF)
The following slide deck was published by DiaSorin S.p.A.- Published at
- by globenewswire.com
neutralneutralStereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir
ST. LOUIS, July 18, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention,...- Published at
- by globenewswire.com
mixedmixed[Latest] Global Cardiac Troponin Market Size/Share Worth USD 4.2 Billion by 2033 at a 12.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Gr
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Cardiac Troponin Market...- Published at
- by globenewswire.com
mixedmixedCardiac Marker Testing Market Surges to USD 8.69 Billion by 2031, Propelled by 8.8% CAGR - Verified Market Research®
The cardiac marker testing market is driven by the rising prevalence of cardiovascular diseases, increasing awareness of early diagnosis, and advancements...- Published at
- by globenewswire.com
neutralneutralIn Vitro Diagnostics Market is Expected to Reach $119.4 billion | MarketsandMarkets™
Chicago, April 16, 2024 (GLOBE NEWSWIRE) -- In Vitro Diagnostics market in terms of revenue was estimated to be worth $85.2 billion in 2024 and is poised...- Published at
- by globenewswire.com
mixedmixedNorovirus Diagnostics Market To Reach USD 130.4 Billion By 2032 | DataHorizzon Research
The norovirus diagnostics market was valued at USD 65.5 Billion in 2023 and is expected to reach USD 130.4 Billion by 2032 at a CAGR of 7.9%....- Published at
- by globenewswire.com
mixedmixedInfluenza Diagnostics Market Share Estimated to Reach USD 1.46 Billion By 2032, at 7.1% CAGR Growth: Polaris Market Research
The global influenza diagnostics market size and share are currently valued at USD 0.79 billion in 2023. It is anticipated to generate an estimated revenue...- Published at
- by globenewswire.com
positivepositiveHelicobacter Pylori Non-invasive Testing Market to Exceed USD 788.2 million by 2031, with a CAGR of 4.2%: Transparency Market Research, Inc
Intense competition among key players drives innovation and product differentiation in the helicobacter pylori non-invasive testing market....- Published at
- by globenewswire.com
mixedmixedBlood Transfusion Diagnostics Market revenue to reach USD 9 Billion by 2033, says Research Nester
Key blood transfusion diagnostics market players include Immucor, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Quotient Limited, Beckman Coulter,...- Published at
- by globenewswire.com
mixedmixedAutoimmune Diseases Diagnostics Global Market to Surpass 6 Billion Mark by 2028 | DelveInsight
The increasing prevalence of autoimmune disorders, including conditions like Rheumatoid Arthritis, Type I Diabetes, and Addison's Disease, is a key driver...- Published at
- by globenewswire.com
mixedmixedBlood Screening Market revenue to hit USD 5.03 Billion by 2035, says Research Nester
Key blood screening market players include Abbott Laboratories, Grifols, S.A., Quotient Limited, Thermo Fisher Scientific Inc., BD, Ortho al Diagnostics,...